KRTCAP2 antibody (C-Term)
Quick Overview for KRTCAP2 antibody (C-Term) (ABIN655129)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 134-162, C-Term
-
Predicted Reactivity
- Rat
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This KTAP2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 134-162 amino acids from the C-terminal region of human KTAP2.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- WB: 1:1000. WB: 1:1000. IHC-P: 1:10~50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Expiry Date
- 6 months
-
-
- KRTCAP2 (Keratinocyte Associated Protein 2 (KRTCAP2))
-
Alternative Name
- KTAP2
-
Background
- E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2L6 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates, such as UCKL1. Involved in the cytolytic activity of natural killer cells and cytotoxic T-cells.
-
Molecular Weight
- 14679
-
Gene ID
- 200185
-
NCBI Accession
- NP_776251
-
UniProt
- Q8N6L1
Target
-